Recursion Pharmaceuticals Inc [RXRX] Is Currently -0.89 below its 200 Period Moving Avg: What Does This Mean?
Recursion Pharmaceuticals Inc [NASDAQ: RXRX] price plunged by -0.89 percent to reach at -$0.06. The one-year RXRX stock forecast points to a potential upside of 42.5. The average equity rating for RXRX stock is currently 2.43, trading closer to a bullish pattern in the stock